Marius Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Marius Pharmaceuticals is a biopharmaceutical company that develops oral testosterone replacement therapy to bring novel treatments to a range of diseases with unmet medical needs. The company's solutions overcome many of the problems associated with currently approved products and their proprietary delivery technology has reached optimal absorption with all meal types resulting in a higher bioavailability, providing men suffering from low testosterone with safe and efficacious treatment. The company was founded in 2017 and headquartered in Raleigh, North Carolina.
Marius Pharmaceuticals has raised $6.0M across 1 funding round on record, the most recent an undisclosed round of $6.0M announced in Oct 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Marius Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Oct 2021.
Marius Pharmaceuticals Funding Rounds
Marius Pharmaceuticals Founders and Leadership Team
Contact details for the Marius Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Marius Pharmaceuticals Funding Compared to Other Biotechnology Startups
Marius Pharmaceuticals' latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Marius Pharmaceuticals in Biotechnology and Raleigh
Companies Similar to Marius Pharmaceuticals
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Marius Pharmaceuticals Funding FAQs
What does Marius Pharmaceuticals do?
Marius Pharmaceuticals is a biopharmaceutical company that develops oral testosterone replacement therapy to bring novel treatments to a range of diseases with unmet medical needs. The company's solutions overcome many of the problems associated with currently approved products and their proprietary delivery technology has reached optimal absorption with all meal types resulting in a higher bioavailability, providing men suffering from low testosterone with safe and efficacious treatment. The company was founded in 2017 and headquartered in Raleigh, North Carolina.
How much funding has Marius Pharmaceuticals raised?
Marius Pharmaceuticals has raised $6.0M across 1 round on record. The most recent is an undisclosed round of $6.0M announced in Oct 2021.
When did Marius Pharmaceuticals last raise funding?
Marius Pharmaceuticals' most recent funding round on record is an undisclosed round of $6.0M, announced in Oct 2021.
Who is the CEO of Marius Pharmaceuticals?
Shalin Shah is listed as CEO at Marius Pharmaceuticals.
Where is Marius Pharmaceuticals headquartered?
Marius Pharmaceuticals is based in Raleigh, North Carolina, United States.
How many employees does Marius Pharmaceuticals have?
Marius Pharmaceuticals is in the 1-10 employee band.
How does Marius Pharmaceuticals' funding compare to other Biotechnology startups?
Marius Pharmaceuticals' latest round of $6.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Marius Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Marius Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.